相关实验视频

Updated: Jul 17, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

针对LAG-3,TIM-3和TIGIT进行癌症免疫治疗

Letong Cai¹, Yuchen Li¹, Jiaxiong Tan¹

¹Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China.

Journal of hematology & oncology

|September 5, 2023

概括

免疫检查点阻塞 (ICB) 是重要的癌症疗法,但LAG-3,TIM-3和TIGIT等新目标提供了更广泛的治疗潜力. 本综述详细介绍了它们的机制和改善癌症免疫治疗的临床前景.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

免疫检查点阻塞 (ICBs) 代表了癌症治疗的重大进展.
目前针对CTLA-4和PD-1/PD-L1的ICB并非对所有患者都有好处.
新的免疫检查点蛋白 (ICP) 正在研究以克服抗性.

研究的目的:

审查第二波ICP目标的发现和治疗潜力.
要总结LAG-3,TIM-3和TIGIT的免疫疗法机制.
为这些新兴的ICB目标整合临床前和临床数据.

主要方法:

科学出版物和临床试验数据的文献综述.
对LAG-3,TIM-3和TIGIT的发现和生物机制的分析.
评估针对这些蛋白质的ICBs的临床前疗效和临床试验结果.

主要成果:

淋巴细胞激活基因-3 (LAG-3),T细胞免疫球蛋白和含有粘素域-3 (TIM-3) 以及具有免疫球蛋白和氨酸基抑制动机 (ITIM) 域 (TIGIT) 的T细胞免疫受体是第二波的关键目标.
这些目标在临床前模型和对固体瘤和白血病的早期临床试验中表现有前途.
了解它们的机制对于优化组合策略至关重要.

结论:

在癌症免疫治疗方面,LAG-3,TIM-3和TIGIT是有前途的下一代目标.
进一步的研究和临床试验至关重要,以充分实现ICBs对这些目标的潜力.
这些ICB可以为那些对当前疗法没有反应的患者扩大治疗选择.

关键词:

现场行动组-3 在白血病中,白血病.固体瘤是一个固体瘤.这是一个紧张的紧张.在TIM-3中,TIM-3是TIM-3.

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...